Boulder’s TissueForm selected for MedTech Innovator accelerator
LOS ANGELES — Boulder-headquartered TissueForm Inc. is among the startup firms selected to participate in the upcoming MedTech Innovator accelerator program.
The 2026 accelerator cohort of 65 companies will “participate in MTI’s flagship four-month program designed and proven to de-risk medtech innovation and accelerate the path to U.S. market success,” MedTech Innovator said in a news release.
TissueForm, according to its website, is “pioneering natural implants that restore lost structure with the structure your body knows best. By preserving the body’s natural blueprint, we enable integration and lasting functional structure where current solutions fall short.
The company has been registered since 2019 to 2147 Kincaid Place in Boulder, Colorado Secretary of State records show.
Boulder-headquartered TissueForm Inc. is among the startup firms selected to participate in the upcoming MedTech Innovator accelerator program.
Related Posts
-
Woofie’s of Boulder, a new pet care business, will have a grand opening party on…
-
A trio of Boulder startup scene veterans is reviving the local Techstars accelerator program, which…
-
A pair of Boulder startup companies are among 10 recently chosen to participate in an…
-
The City of Boulder and Boulder County will host a community roundtable on April 12…
